Impact of Perioperative Blood Transfusion on Postoperative Complications and Prognosis of Gastric Adenocarcinoma Patients with Different Preoperative Hemoglobin Value
Table 2
Comparison of clinicopathological features of transfused and nontransfused patients in POHb between 70 and 100 g/L or >100 g/L subgroups.
Categories
Transfused ones with POHb between 70 and 100 g/L
Nontransfused with POHb between 70 and 100 g/L
value
Transfused ones with POHb >100 g/L
Nontransfused with POHb >100 g/L
value
(%)
(%)
(%)
(%)
Age
Mean ± SD
60.2 ± 10.8
57.4 ± 12.6
0.051
58.1 ± 11.2
55.7 ± 11.4
0.020
Gender
Male
108 (72.0)
69 (64.5)
0.200
100 (70.9)
536 (71.8)
0.841
Female
42 (28.0)
38 (35.5)
41 (29.1)
211 (28.2)
Combined organ resection
Yes
16 (10.7)
1 (0.9)
0.002
22 (15.6)
30 (4.0)
<0.001
No
134 (89.3)
106 (99.1)
119 (84.4)
717 (96.0)
Type of gastrectomy
DG
83 (55.3)
62 (57.9)
0.916
71 (50.4)
457 (61.2)
0.024
TG
39 (26)
26 (24.3)
38 (27.0)
134 (17.9)
PG
28 (18.7)
19 (17.8)
32 (22.6)
156 (20.9)
Open approach
Open surgery
141 (94.0)
93 (86.9)
0.050
138 (97.9)
632 (84.6)
<0.001
Laparoscopic assisted
9 (6.0)
14 (13.1)
3 (2.1)
115 (15.4)
Longitudinal location
U
30 (20.0)
27 (25.2)
0.279
34 (24.1)
194 (26.0)
0.024
M
26 (17.3)
16 (15.0)
27 (19.1)
86 (11.5)
L
90 (60.0)
64 (59.8)
76 (53.9)
459 (61.4)
Whole
4 (2.7)
0 (0)
4 (2.9)
8 (1.1)
Differentiation grade
Well/moderate
22 (14.7)
17 (15.9)
0.788
16 (11.3)
154 (20.6)
0.010
Poor/undifferentiated
128 (85.7)
90 (84.1)
125 (88.7)
593 (79.4)
Macroscopic type
Types 0–2
91 (60.7)
64 (59.8)
0.890
86 (61.0)
505 (67.6)
0.127
Types 3–4
59 (39.3)
43 (40.2)
55 (39.0)
242 (32.4)
Tumor size (cm)
Mean ± SD
5.9 ± 2.6
5.5 ± 3.0
0.262
5.1 ± 2.5
4.5 ± 2.3
0.009
≤4.5
47 (31.3)
41 (38.3)
0.245
60 (42.6)
420 (56.2)
>4.5
103 (68.7)
66 (61.7)
81 (57.4)
327 (43.8)
T stage
T1
12 (8.0)
15 (14.0)
0.227
15 (10.6)
177 (23.7)
<0.001
T2
20 (13.3)
16 (15.0)
12 (8.5)
105 (14.1)
T3
6 (4.0)
2 (1.9)
5 (3.5)
42 (5.6)
T4
112 (74.7)
74 (69.1)
109 (77.4)
423 (56.6)
N stage
N0
35 (23.4)
32 (29.9)
0.228
34 (24.1)
287 (38.4)
<0.001
N1
32 (21.3)
20 (18.7)
26 (18.4)
134 (18.0)
N2
32 (21.3)
26 (24.3)
27 (19.1)
142 (19.0)
N3a
36 (24.0)
21 (19.6)
38 (27.0)
136 (18.2)
N3b
15 (10.0)
8 (7.5)
16 (11.4)
48 (6.4)
TNM stage
I/II
49 (32.7)
46 (43.0)
0.091
44 (31.2)
364 (48.7)
<0.001
III
101 (67.3)
61 (57.0)
97 (68.8)
383 (51.3)
Operation time (min)
Mean ± SD
236.9 ± 55.2
228.4 ± 51.4
0.231
249.3 ± 64.6
233.5 ± 49.6
0.008
Intraoperative blood loss (mL)
Mean ± SD
498.5 ± 215.2
408.5 ± 212.1
0.001
625.9 ± 421.5
415.0 ± 191.7
0.002
Postoperative complications
Yes
32 (21.3)
18 (16.8)
0.426
37 (26.2)
134 (17.9)
0.027
No
118 (78.7)
89 (83.2)
104 (73.8)
613 (82.1)
Postoperative hospital stay
Mean ± SD
12.0 ± 8.4
11.2 ± 6.7
0.428
13.2 ± 13.7
11.7 ± 10.2
0.146
SD: standard deviation, DG: distal gastrectomy, TG: total gastrectomy, PG: proximal gastrectomy, U: upper, M: middle, and L: lower.
